Pentoxifylline - Isotope Labelled Standards
References
FAQ's
References
- Chemische Werke Albert, Xanthine derivatives, GB1079267A, August 16, 1967
- Chivers, D. A.; Birkett, D. J.; Miners, J. O, Simultaneous determination of pentoxifylline and its hydroxy metabolite in plasma by high-performance liquid chromatography, Journal of Chromatography, Biomedical Applications, Volume: 225, Issue: 1, Pages: 261-5, 1981
Frequently Asked Questions
Can Pentoxifylline impurities be removed?
Pentoxifylline impurities are reduced but not removed.
What is the significance of analyzing Pentoxifylline impurities?
Analyzing Pentoxifylline impurities is significant for ensuring safety, efficacy, and quality, as it can impact its effectiveness and pose potential risks to patients.
How are Pentoxifylline impurities synthesized?
Pentoxifylline impurities are synthesized through various pathways during the synthetic process, including incomplete reactions, side reactions, and their presence in starting materials or reagents.
What are the temperature conditions required to store Pentoxifylline impurities?
Pentoxifylline impurities are stored at a regulated room temperature of 2-8°C or as specified on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.